| Product details |
Supply Impact Dates |
Further Details |
APO-FENTANYL fentanyl 100 micrograms/hour transdermal drug delivery system sachet AUST R: 152575Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Sandoz Pty Ltd
Phone:
1800 726 369
|
From
18 Dec 2024
to
31 Mar 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
APO-FENTANYL fentanyl 25 micrograms/hour transdermal drug delivery system sachet AUST R: 152574Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Sandoz Pty Ltd
Phone:
1800 726 369
|
From
14 Mar 2025
to
14 Mar 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in demand due to other sponsors unable to supply
|
APO-FENTANYL fentanyl 50 micrograms/hour transdermal drug delivery system sachet AUST R: 152573Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Sandoz Pty Ltd
Phone:
1800 726 369
|
From
02 Apr 2025
to
02 Apr 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in demand due to other sponsors unable to supply
|
APO-FENTANYL fentanyl 75 micrograms/hour transdermal drug delivery system sachet AUST R: 152570Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Sandoz Pty Ltd
Phone:
1800 726 369
|
From
23 Apr 2025
to
24 Apr 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
FENTANYL SANDOZ fentanyl 100 micrograms/hour transdermal drug delivery system sachet AUST R: 152576Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Sandoz Pty Ltd
Phone:
1800726369
|
From
17 Apr 2025
to
08 May 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in demand due to other sponsors unable to supply
|
FENTANYL SANDOZ fentanyl 50 micrograms/hour transdermal drug delivery system sachet AUST R: 152571Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Sandoz Pty Ltd
Phone:
1800726369
|
From
14 Jan 2025
to
06 Mar 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in demand due to other sponsors unable to supply
|
DENPAX fentanyl 100 micrograms/hour transdermal patch AUST R: 163067Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Alphapharm Pty Ltd
Phone:
1800274276
|
Deletion from market:
05 Aug 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available. Unregistered products have also been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
|
DENPAX fentanyl 12 micrograms/hour transdermal patch AUST R: 163066Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Alphapharm Pty Ltd
Phone:
1800 314 527
|
Deletion from market:
07 Aug 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available. Unregistered products have also been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
|
DENPAX fentanyl 25 micrograms/hour transdermal patch AUST R: 163068Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Alphapharm Pty Ltd
Phone:
1800274276
|
Deletion from market:
30 Nov 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available. Unregistered products have also been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
|
DENPAX fentanyl 50 micrograms/hour transdermal patch AUST R: 163064Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Alphapharm Pty Ltd
Phone:
1800274276
|
Deletion from market:
30 Dec 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available. Unregistered products have also been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
|
DENPAX fentanyl 75 micrograms/hour transdermal patch AUST R: 163065Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Alphapharm Pty Ltd
Phone:
1800274276
|
Deletion from market:
07 Aug 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available. Unregistered products have also been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
|
DUROGESIC fentanyl 100 micrograms/h transdermal patch sachet AUST R: 112371Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Janssen-Cilag Pty Ltd
Phone:
1800226334
|
Deletion from market:
14 Apr 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Manufacturing
Management action:
Alternative generic products are available. Unregistered products have also been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
|
DUROGESIC fentanyl 12 micrograms/h transdermal patch sachet AUST R: 116828Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Janssen-Cilag Pty Ltd
Phone:
1800226334
|
Deletion from market:
14 Apr 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Manufacturing
Management action:
Alternative generic products are available. Unregistered products have also been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
|
DUROGESIC fentanyl 25 micrograms/h transdermal patch sachet AUST R: 112368Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Janssen-Cilag Pty Ltd
Phone:
1800226334
|
Deletion from market:
14 Apr 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Manufacturing
Management action:
Alternative generic products are available. Unregistered products have also been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
|
DUROGESIC fentanyl 50 micrograms/h transdermal patch sachet AUST R: 112369Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Janssen-Cilag Pty Ltd
Phone:
1800226334
|
Deletion from market:
14 Apr 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Manufacturing
Management action:
Alternative generic products are available. Unregistered products have also been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
|
DUROGESIC fentanyl 75 micrograms/h transdermal patch sachet AUST R: 112370Active ingredients:
fentanyl
Dosage form:
Drug delivery system, transdermal
Sponsor:
Janssen-Cilag Pty Ltd
Phone:
1800226334
|
Deletion from market:
14 Apr 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Manufacturing
Management action:
Alternative generic products are available. Unregistered products have also been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
|